Please assess the completion status of the following clinical trial:

Trial Title: Effects of Two Doses of a Common Cold Treatment on Alertness

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
* Participants with symptoms of cold \< 96 hours, rating of at least '2' on malaise at least 4 other symptoms of cold.~* No history of clinically significant perennial rhinitis, no recent antibiotic, antihistamine or cold treatment, no caffeine in the previous 12 hours, no psychoactive medication in the 14 days prior to screening, no pregnancy, breastfeeding or participation in this trial, or another trial in the 30 days prior to screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- highest dose Paracetamol + caffeine (Type: ACTIVE_COMPARATOR): highest dose of Paracetamol and caffeine
- low-dose Paracetamol + caffeine (Type: ACTIVE_COMPARATOR): lowest dose of Paracetamol and caffeine
- high dose paracetamol (Type: ACTIVE_COMPARATOR): highest dose paracetamol
- low dose paracetamol (Type: ACTIVE_COMPARATOR): lowest dose paracetamol

Based on this trial design, predict the completion outcome and termination type (if applicable).